- Marketwired•3 days agoTheratechnologies to Move Forward With Development of New Single Vial Formulation for EGRIFTA(R) (Tesamorelin for Injection)
Theratechnologies Inc. today announced that it will move forward with the development of the F4 single vial formulation instead of the 2mg/vial presentation. The introduction of a single vial presentation ...
- Marketwired•4 days ago
Theratechnologies Inc. announced today that it will issue its financial results for the third quarter ended August 31, 2016, on Tuesday, October 4, 2016, before markets open.
- Capital Cube•16 days ago
Categories: Fundamental Analysis Yahoo Finance Click here to see latest analysis Capitalcube gives Theratechnologies, Inc. a score of 91. Our analysis is based on comparing Theratechnologies, Inc. with the following peers – Aeterna Zentaris Inc., Cynapsus Therapeutics Inc., Nuvo Pharmaceuticals Inc., Cipher Pharmaceuticals Inc., ProMetic Life Sciences Inc., Sernova Corp., Telesta Therapeutics Inc., BELLUS Health Inc., DiaMedica Inc. and Intellipharmaceutics ... Read more (Read more...)
Theratechnologies Inc. (TH.TO)
Toronto - Toronto Delayed Price. Currency in CAD
|Day's Range||2.87 - 2.99|
|52wk Range||1.26 - 3.74|
|1y Target Est||N/A|
|P/E Ratio (ttm)||268.18|
|Avg Vol (3m)||127,123|
|Dividend & Yield||N/A (N/A)|